EPCAT II STUDY (Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty)
Description
EPCAT II STUDY (Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty)
Entity: Capital District Health Authority
Type: Service
Awarded to: Ford's Family Pharmacy
Award Amount: $13,153.85 CAD
Find tenders like this automatically
Set up alerts and filters that match your business โ never miss a relevant opportunity again.
About This Opportunity
This is a services contract in the health and medical services and Research sectors, with a focus on Pharmaceuticals. Located in Canada, North America, this opportunity is open to firms and consortiums, with an estimated budget of CAD 13,154.
Published through Nova Scotia Tenders, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. This contract has already been awarded. The information is published for transparency and market intelligence purposes.